Latest Regulatory News

Rox Resources (ASX – RXL) has delivered a comprehensive update on its Youanmi Gold Project, highlighting a compelling Definitive Feasibility Study and significant funding progress that set the stage for production in 2026.

Genmin Limited has successfully completed the first tranche of its capital raising, issuing over 131 million shares to fund its flagship Baniaka iron ore project in Gabon, targeting production by late 2026.

Magnetite Mines has cleared a crucial regulatory hurdle as its Razorback Iron Ore Project’s Mining Lease Proposal passes the South Australian Government’s validity assessment, paving the way for detailed technical review and public consultation.

Metroglass has reported a 5% revenue decline in its half-year results but achieved a significant reduction in net debt and improved profitability, signaling progress in its turnaround strategy amid challenging market conditions.

Brightstar Resources outlines a bold growth strategy targeting over 200,000 ounces of annual gold production by 2029, leveraging its Western Australian assets and aggressive drilling programs. The company’s recent feasibility studies and acquisitions position it as a rising gold producer in the region.

Elementos Limited has announced a $2.9 million non-renounceable entitlement offer alongside a $6 million initial placement to fund key project developments, including the Oropesa Tin Project and Cleveland Tin and Tungsten Project.

Dusk Group Limited has addressed an ASX compliance query regarding the delayed disclosure of a director’s interest change, attributing the lapse to an administrative oversight while reaffirming its commitment to regulatory compliance.

Gold Hydrogen Limited has confirmed elevated levels of natural hydrogen and helium at its Ramsay 3 well, marking a significant step in its 2025 drilling campaign and reinforcing the potential of its South Australian project.

Cauldron Energy Limited addresses a sharp share price rise, attributing it to strong uranium exploration results and market speculation linked to a sector takeover.

Austral Gold has received TSX Venture Exchange approval to issue 1,025,077 shares as repayment of accrued interest on convertible notes, following a recent principal conversion. This move reflects ongoing capital management efforts amid the company’s growth strategy.

Infini Resources Limited’s I88OA securities have been suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

Cynata Therapeutics has completed the final patient visit in its Phase 3 trial for CYP-004, targeting knee osteoarthritis, with results expected in mid-2026. This milestone advances hopes for a disease-modifying therapy in a market desperate for new options.